Global Inhalation Sedatives Market Research Report 2023

Publication ID:

PB502235607

Publication Date:

February 28, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Inhalation Sedatives are the drugs used to induce or maintain inhalation sedation, which is a type of conscious sedation where a drug is inhaled to suppress the central nervous system activity so that there is no much stress on the patient during a surgical process or a treatment and responds to the physician commands without protective reflexes.
Highlights
The global Inhalation Sedatives market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Inhalation Sedatives is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Inhalation Sedatives is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Inhalation Sedatives in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Inhalation Sedatives include AbbVie Inc, Baxter International Inc, Novatis(Sandoz), Fresenius, Halocarbon, Hikma Pharmaceuticals PLC, Piramal Enterprises Ltd, Troikaa Pharmaceuticals Ltd and Jiangsu Hengrui Medicine Co.,Ltd, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inhalation Sedatives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalation Sedatives.
The Inhalation Sedatives market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Inhalation Sedatives market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhalation Sedatives companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
AbbVie Inc
Baxter International Inc
Novatis(Sandoz)
Fresenius
Halocarbon
Hikma Pharmaceuticals PLC
Piramal Enterprises Ltd
Troikaa Pharmaceuticals Ltd
Jiangsu Hengrui Medicine Co.,Ltd
Lunan Pharmaceutical Group Co.,Ltd
Segment by Type
Sevoflurane
Desflurane
Isoflurane
Nitrous Oxide
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inhalation Sedatives companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inhalation Sedatives Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sevoflurane
1.2.3 Desflurane
1.2.4 Isoflurane
1.2.5 Nitrous Oxide
1.3 Market by Application
1.3.1 Global Inhalation Sedatives Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inhalation Sedatives Market Perspective (2018-2029)
2.2 Inhalation Sedatives Growth Trends by Region
2.2.1 Global Inhalation Sedatives Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Inhalation Sedatives Historic Market Size by Region (2018-2023)
2.2.3 Inhalation Sedatives Forecasted Market Size by Region (2024-2029)
2.3 Inhalation Sedatives Market Dynamics
2.3.1 Inhalation Sedatives Industry Trends
2.3.2 Inhalation Sedatives Market Drivers
2.3.3 Inhalation Sedatives Market Challenges
2.3.4 Inhalation Sedatives Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inhalation Sedatives Players by Revenue
3.1.1 Global Top Inhalation Sedatives Players by Revenue (2018-2023)
3.1.2 Global Inhalation Sedatives Revenue Market Share by Players (2018-2023)
3.2 Global Inhalation Sedatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Inhalation Sedatives Revenue
3.4 Global Inhalation Sedatives Market Concentration Ratio
3.4.1 Global Inhalation Sedatives Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inhalation Sedatives Revenue in 2022
3.5 Inhalation Sedatives Key Players Head office and Area Served
3.6 Key Players Inhalation Sedatives Product Solution and Service
3.7 Date of Enter into Inhalation Sedatives Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Inhalation Sedatives Breakdown Data by Type
4.1 Global Inhalation Sedatives Historic Market Size by Type (2018-2023)
4.2 Global Inhalation Sedatives Forecasted Market Size by Type (2024-2029)
5 Inhalation Sedatives Breakdown Data by Application
5.1 Global Inhalation Sedatives Historic Market Size by Application (2018-2023)
5.2 Global Inhalation Sedatives Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Inhalation Sedatives Market Size (2018-2029)
6.2 North America Inhalation Sedatives Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Inhalation Sedatives Market Size by Country (2018-2023)
6.4 North America Inhalation Sedatives Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Inhalation Sedatives Market Size (2018-2029)
7.2 Europe Inhalation Sedatives Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Inhalation Sedatives Market Size by Country (2018-2023)
7.4 Europe Inhalation Sedatives Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Inhalation Sedatives Market Size (2018-2029)
8.2 Asia-Pacific Inhalation Sedatives Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Inhalation Sedatives Market Size by Region (2018-2023)
8.4 Asia-Pacific Inhalation Sedatives Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Inhalation Sedatives Market Size (2018-2029)
9.2 Latin America Inhalation Sedatives Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Inhalation Sedatives Market Size by Country (2018-2023)
9.4 Latin America Inhalation Sedatives Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inhalation Sedatives Market Size (2018-2029)
10.2 Middle East & Africa Inhalation Sedatives Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Inhalation Sedatives Market Size by Country (2018-2023)
10.4 Middle East & Africa Inhalation Sedatives Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Company Detail
11.1.2 AbbVie Inc Business Overview
11.1.3 AbbVie Inc Inhalation Sedatives Introduction
11.1.4 AbbVie Inc Revenue in Inhalation Sedatives Business (2018-2023)
11.1.5 AbbVie Inc Recent Development
11.2 Baxter International Inc
11.2.1 Baxter International Inc Company Detail
11.2.2 Baxter International Inc Business Overview
11.2.3 Baxter International Inc Inhalation Sedatives Introduction
11.2.4 Baxter International Inc Revenue in Inhalation Sedatives Business (2018-2023)
11.2.5 Baxter International Inc Recent Development
11.3 Novatis(Sandoz)
11.3.1 Novatis(Sandoz) Company Detail
11.3.2 Novatis(Sandoz) Business Overview
11.3.3 Novatis(Sandoz) Inhalation Sedatives Introduction
11.3.4 Novatis(Sandoz) Revenue in Inhalation Sedatives Business (2018-2023)
11.3.5 Novatis(Sandoz) Recent Development
11.4 Fresenius
11.4.1 Fresenius Company Detail
11.4.2 Fresenius Business Overview
11.4.3 Fresenius Inhalation Sedatives Introduction
11.4.4 Fresenius Revenue in Inhalation Sedatives Business (2018-2023)
11.4.5 Fresenius Recent Development
11.5 Halocarbon
11.5.1 Halocarbon Company Detail
11.5.2 Halocarbon Business Overview
11.5.3 Halocarbon Inhalation Sedatives Introduction
11.5.4 Halocarbon Revenue in Inhalation Sedatives Business (2018-2023)
11.5.5 Halocarbon Recent Development
11.6 Hikma Pharmaceuticals PLC
11.6.1 Hikma Pharmaceuticals PLC Company Detail
11.6.2 Hikma Pharmaceuticals PLC Business Overview
11.6.3 Hikma Pharmaceuticals PLC Inhalation Sedatives Introduction
11.6.4 Hikma Pharmaceuticals PLC Revenue in Inhalation Sedatives Business (2018-2023)
11.6.5 Hikma Pharmaceuticals PLC Recent Development
11.7 Piramal Enterprises Ltd
11.7.1 Piramal Enterprises Ltd Company Detail
11.7.2 Piramal Enterprises Ltd Business Overview
11.7.3 Piramal Enterprises Ltd Inhalation Sedatives Introduction
11.7.4 Piramal Enterprises Ltd Revenue in Inhalation Sedatives Business (2018-2023)
11.7.5 Piramal Enterprises Ltd Recent Development
11.8 Troikaa Pharmaceuticals Ltd
11.8.1 Troikaa Pharmaceuticals Ltd Company Detail
11.8.2 Troikaa Pharmaceuticals Ltd Business Overview
11.8.3 Troikaa Pharmaceuticals Ltd Inhalation Sedatives Introduction
11.8.4 Troikaa Pharmaceuticals Ltd Revenue in Inhalation Sedatives Business (2018-2023)
11.8.5 Troikaa Pharmaceuticals Ltd Recent Development
11.9 Jiangsu Hengrui Medicine Co.,Ltd
11.9.1 Jiangsu Hengrui Medicine Co.,Ltd Company Detail
11.9.2 Jiangsu Hengrui Medicine Co.,Ltd Business Overview
11.9.3 Jiangsu Hengrui Medicine Co.,Ltd Inhalation Sedatives Introduction
11.9.4 Jiangsu Hengrui Medicine Co.,Ltd Revenue in Inhalation Sedatives Business (2018-2023)
11.9.5 Jiangsu Hengrui Medicine Co.,Ltd Recent Development
11.10 Lunan Pharmaceutical Group Co.,Ltd
11.10.1 Lunan Pharmaceutical Group Co.,Ltd Company Detail
11.10.2 Lunan Pharmaceutical Group Co.,Ltd Business Overview
11.10.3 Lunan Pharmaceutical Group Co.,Ltd Inhalation Sedatives Introduction
11.10.4 Lunan Pharmaceutical Group Co.,Ltd Revenue in Inhalation Sedatives Business (2018-2023)
11.10.5 Lunan Pharmaceutical Group Co.,Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

AbbVie Inc
Baxter International Inc
Novatis(Sandoz)
Fresenius
Halocarbon
Hikma Pharmaceuticals PLC
Piramal Enterprises Ltd
Troikaa Pharmaceuticals Ltd
Jiangsu Hengrui Medicine Co.,Ltd
Lunan Pharmaceutical Group Co.,Ltd

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂